Get started
EnerSyn Global Inc. logo

ESYN

NASDAQ

EnerSyn Global Inc.

SectorHealth CareIndustryOther PharmaceuticalsIPO2022
Follow + get alerts
Website

EnerSyn Global Inc. (ESYN) is an Other Pharmaceuticals company listed on NASDAQ. There were no new wire items for ESYN in the last 30 days.

Previously known as HWH International Inc., the Company operates as a purpose-driven lifestyle company encompassing differentiated offerings to develop new pathways to help people in their pursuit of Health, Wealth and Happiness. The Company's management team has begun to evaluate a range of additional growth and investment opportunities that it believes can build long-term shareholder value and drive strong, sustainable growth. The Company intends to pursue such opportunities selectively and prudently, in a manner management deems beneficial to, and aligned with the long-term interests of its stockholders. The Company believes that energy represents a new addition to the Company that may provide favorable opportunities.

Financial highlights

Full financials
Revenue, TTM
$389.7K
Revenue growth
-68.5%
Net income, TTM
-$2.65M
Net margin
-680.2%
Free cash flow, TTM
-$955.3K
Cash
$1.51M

For the twelve months ended Jun 30, 2026, from SEC filings. Not investment advice.

Latest news

0 items

No recent news.

ESYN FAQ

9 questions
  • What does EnerSyn Global Inc. do?
    Previously known as HWH International Inc., the Company operates as a purpose-driven lifestyle company encompassing differentiated offerings to develop new pathways to help people in their pursuit of Health, Wealth and Happiness. The Company's management team has begun to evaluate a range of additional growth and investment opportunities that it believes can build long-term shareholder value and drive strong, sustainable growth. The Company intends to pursue such opportunities selectively and prudently, in a manner management deems beneficial to, and aligned with the long-term interests of...
  • What is ESYN revenue?
    EnerSyn Global Inc. (ESYN) reported $389.7K of revenue for the twelve months ended Jun 30, 2026. That is down 68.5% from the year before. Revenue for fiscal 2025 was $866.9K.
  • Is ESYN profitable?
    No. EnerSyn Global Inc. reported a net loss of $2.65M for the twelve months ended Jun 30, 2026.
  • How much cash and debt does ESYN have?
    EnerSyn Global Inc. reported $1.51M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does ESYN stock trade?
    EnerSyn Global Inc. (ESYN) is listed on NASDAQ.
  • What sector and industry is ESYN in?
    EnerSyn Global Inc. operates in the Health Care sector, Other Pharmaceuticals industry.
  • When did EnerSyn Global Inc. go public?
    EnerSyn Global Inc. (ESYN) completed its IPO in 2022.
  • What companies are similar to ESYN?
    Notable peers in the same industry include MCK (McKesson Corporation), COR (Cencora Inc.), CAH (Cardinal Health Inc.), HLF (Herbalife Ltd.), NUS (Nu Skin Enterprises Inc.). Compare ESYN side-by-side with any of them on Quantisnow.
  • How can I track ESYN on Quantisnow?
    Quantisnow aggregates EnerSyn Global Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ESYN to receive live email and push alerts on every new disclosure.